Research letter
Immunosuppressive biologics did not increase the risk of COVID-19 or subsequent mortality: A retrospective matched cohort study from Massachusetts

https://doi.org/10.1016/j.jaad.2021.08.065Get rights and content

Key words

atopic dermatitis
autoimmune diseases
biologics
COVID-19
IL-4A
IL-12/22
IL-17A
psoriasis
systemic immunosuppression
systemic lupus erythematosus
TNF

Cited by (0)

Drs Pahalyants and Murphy are cofirst authors.

IRB approval status: Approved by the institutional review boards of Mass General Brigham (Protocol 2020P001191) and Massachusetts Department of Public Health (Protocol 1606024-2).

Funding sources: None.

View Abstract